Yoshimoto T, Yamamoto S, Okuma M, Hayaishi O
J Biol Chem. 1977 Aug 25;252(16):5871-4.
The thromboxane synthetase system of the microsomes of bovine blood platelets was solubilized by the treatment with Triton X-100. The solubilized preparation was separated into two enzyme fractions by DEAE-cellulose chromatography. One catalyzed the formation of prostaglandin H2 from arachidonic acid in the presence of heme and tryptophan. The other fraction converted prostaglandin H2 to thromboxane B2 and 12L-hydroxy-5,8,10-heptadecatrienoic acid. However, incubation of the latter fraction with prostaglandin H2 at lower temperature produced an unstable compound with platelet-aggregating activity, which was presumably thromboxane A2 and which decomposed readily to thromboxane B2 and 12L-hydroxy-5,8,10-heptadecatrienoic acid.
用Triton X-100处理牛血小板微粒体的血栓素合成酶系统使其溶解。通过DEAE-纤维素色谱法将溶解的制剂分离成两个酶组分。一个在血红素和色氨酸存在下催化花生四烯酸形成前列腺素H2。另一个组分将前列腺素H2转化为血栓素B2和12L-羟基-5,8,10-十七碳三烯酸。然而,在较低温度下将后一组分与前列腺素H2一起温育会产生一种具有血小板聚集活性的不稳定化合物,推测该化合物为血栓素A2,它很容易分解为血栓素B2和12L-羟基-5,8,10-十七碳三烯酸。